Endocrinol Metab.  2016 Jun;31(2):343-344. 10.3803/EnM.2016.31.2.343.

18F-FDG PET/CT-Guided Clinical Management of the Rare Aggressive "Columnar-Cell" Variant of Papillary Thyroid Cancer

• Vadrucci M
• Serio G
• Baroli A

• KMID: 2308866
• DOI: http://doi.org/10.3803/EnM.2016.31.2.343

Abstract

No abstract available.

MeSH Terms

Fluorodeoxyglucose F18*
Thyroid Gland*
Thyroid Neoplasms*
Fluorodeoxyglucose F18

Reference

1. Evans HL. Columnar-cell carcinoma of the thyroid. A report of two cases of an aggressive variant of thyroid carcinoma. Am J Clin Pathol. 1986; 85:77–80.

2. Zhu J, Wang X, Zhang X, Li P, Hou H. Clinicopathological features of recurrent papillary thyroid cancer. Diagn Pathol. 2015; 10:96.

3. Salvatori M, Biondi B, Rufini V. Imaging in endocrinology: 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/ computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up. Eur J Endocrinol. 2015; 173:R115–R130.